Optical inhibition of motor nerve and muscle activity in vivo

Muscle and Nerve

Volumn 47, Issue 6, 2013, Pages 916-921

  Liske, Holly ^a   Towne, Chris ^a   Anikeeva, Polina ^b   Zhao, Shengli ^c   Feng, Guoping ^d   Deisseroth, Karl ^a,e   Delp, Scott ^a  

^a Stanford University   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e STANFORD UNIVERSITY   (United States)

Author keywords

Electromyography; Halorhodopsin; Optogenetics; Sciatic nerve; Spastic hypertonia

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROMYOGRAPHY; FEMALE; MALE; MOTOR NERVE CONDUCTION; MOTOR UNIT POTENTIAL; MOUSE; MUSCLE ACTION POTENTIAL; MUSCLE CONTRACTION; MUSCLE STRENGTH; NONHUMAN; OPTOGENETICS; PRIORITY JOURNAL;

ANIMALS; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; HALORHODOPSINS; MICE; MICE, TRANSGENIC; MOTOR NEURONS; MUSCLE SPASTICITY; MUSCLE, SKELETAL; NEURAL INHIBITION; OPTOGENETICS; SCIATIC NERVE;

EID: 84878348926     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23696     Document Type: Article

References (29)

1. Katz RT, Rymer WZ. Spastic hypertonia: mechanisms and measurement. Arch Phys Med Rehabil 1989;70:144-155.
2. McClelland S, Teng O, Benson LS, Boulis NM. Motor neuron inhibition-based gene therapy for spasticity. Am J Phys Med Rehabil 2007;86:412-421.
3. Simon O, Yelnik AP. Managing spasticity with drugs. Eur J Rehabil Med 2010;46:401-410.
4. Sheean G, McGuire JR. Spastic hypertonia and movement disorders: pathophysiology, clinical presentation, and quantification. PM R 2009;1:827-833.
5. Fenno L, Yizhar O, Deisseroth K. The development and application of optogenetics. Ann Rev Neurosci 2011;34:389-412.
6. Boyden ES, Zhang F, Bamberg E, Nagel G, Deisseroth K. Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci 2005;8:1263-1268.
7. Zhang F, Wang LP, Brauner M, Lewald JF, Kay K, Watzke PG, et al. Multimodal fast optical interrogation of neural circuitry. Nature 2007;446:633-639.
8. Llewellyn ME, Thompson KR, Deisseroth K, Delp SL. Orderly recruitment of motor units under optical control in vivo. Nat Med 2010;16:1161-1165.
9. Bruegmann T, Malan D, Hesse M, Beiert T, Fuegemann CJ, Fleischmann BK, et al. Optogenetic control of heart muscle in vitro and in vivo. Nat Methods 2010;11:897-900.
10. Kanbar R, Stornetta RL, Cash DR, Lewis SJ, Guyenet PG. Photostimulation of Phox2b medullary neurons activates cardiorespiratory function in conscious rats. Am J Respir Crit Care Med 2010;82:1184-1194.
11. Sharp AA, Fromherz S. Optogenetic regulation of leg movement in midstage chick embryos through peripheral nerve stimulation. J Neurophysiol 2011;106:2776-2782.
12. Gradinaru V, Thompson KR, Deisseroth K. eNpHR: a Natronomonas halorhodopsin enganced for optogenetic applications. Brain Cell Biol 2008;36:129-139.
13. Zhao S, Cunha C, Zhang F, Liu Q, Gloss B, Deisseroth K, et al. Improved expression of halorhodopsin for light-induced silencing of neuronal activity. Brain Cell Biol 2008;36:141-154.
14. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012;9:671-675.
15. Zhang F, Gradinaru V, Adamantidis AR, Durand R, Airan RD. de Lecea L, et al. Optogenetic interrogation of neural circuits: technology for probing mammalian brain structures. Nat Protoc 2010;5:439-456.
16. Gupta R, Nassiri N, Hazel A, Bathen M, Mozaffar T. Chronic nerve compression alters Schwann cell myelin architecture in a murine model. Muscle Nerve 2012;45:231-241.
17. Binding J, Arous JB, Léger J-F, Gigan S, Boccara C, Bourdieu L. Brain refractive index measured in vivo with high-NA defocus-corrected full-field OCT and consequences for two-photon microscopy. Opt Express 2011;19:4833-4847.
18. Liebregts MT, McLachlan RS, Leung LS. Hyperthermia induces age-dependent changes in rat hippocampal excitability. Ann Neurol 2002;52:318-326.
19. Aravanis AM, Wang LP, Zhang F, Meltzer LA, Mogri MZ, Schneider MB, et al. An optical neural interface: in vivo control of rodent motor cortex with integrated fiberoptic and optogenetic technology. J Neural Eng 2007;4(suppl):S143-156.
20. Bhadra N, Kilgore KL. High-frequency electrical conduction block of mammalian peripheral motor nerve. Muscle Nerve 2005;32:782-790.
21. Ackermann DM, Foldes EL, Bhadra N, Kilgore KL. Nerve conduction block using combined thermoelectric cooling and high frequency electrical stimulation. J Neurosci Methods 2010;193:72-76.
22. Gradinaru V, Mogri M, Thompson KR, Henderson JM, Deisseroth K. Optical deconstruction of parkinsonian neural circuitry. Science 2009;324:354-359.
23. Towne C, Schneider BL, Kieran D, Redmond DE Jr, Aebischer P. Efficient transduction of non-human primate motor neurons after intramuscular delivery of recombinant AAV serotype 6. Gene Ther 2010;17:141-146.
24. Hollis ER II, Kadoya K, Hirsch M, Samulski RJ, Tuszynski MH. Efficient retrograde neuronal transduction utilizing self-complementary AAV1. Mol Ther 2007;16:296-301.
25. Diester I, Kaufman MT, Mogri M, Pashaie R, Goo W, Yizhar O, et al. An optogenetic toolbox designed for primates. Nat Neurosci 2011;14:387-397.
26. Nathwani AC, Tuddenham EG, Rangarajan S, Rosales C, McIntosh J, Linch DC, et al. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med 2011;365:2357-2365.
27. LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, et al. AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol 2011;10:309-319.
28. Flotte TR, Trapnell BC, Humphries M, Carey B, Calcedo R, Rouhani F, et al. Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim results. Hum Gene Ther 2011;22:1239-1247.
29. Bowles DE, McPhee SW, Li C, Gray SJ, Samulski JJ, Camp AS, et al. Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector. Mol Ther 2012;20:443-455.